Enzyme kinetic and in silico characterization of cytochrome P450 2E1 inhibition by hydro-ethanolic extract of Entada africana and its protective role in acetaminophen-induced hepatotoxicity
{"title":"Enzyme kinetic and in silico characterization of cytochrome P450 2E1 inhibition by hydro-ethanolic extract of Entada africana and its protective role in acetaminophen-induced hepatotoxicity","authors":"Arnaud Fondjo Kouam , Cromwel Tepap Zemnou , Eleonore Ngounou , Felicité Syntia Douanla Somene , Elisabeth Menkem Zeuko'o , Amih Elvis Ofon , Frédéric Nico Njayou , Paul Fewou Moundipa","doi":"10.1016/j.jep.2025.120315","DOIUrl":null,"url":null,"abstract":"<div><h3>Ethnopharmacological relevance</h3><div>Acetaminophen (APAP) poisoning accounts for over 50 % of acute liver failure cases, with N-acetylcysteine remaining the sole antidote despite its limitations. <em>Entada africana</em>, used in ethnomedicine to treat liver disorders, has demonstrated promising antihepatotoxic properties. However, its effects on cytochrome P450 2E1 (CYP2E1) in APAP-toxicity model remain unexplored.</div></div><div><h3>Aims of the study</h3><div>This study investigated the inhibitory effects of the hydro-ethanolic stem bark extract of <em>E. africana</em> (HEA) on CYP2E1 activity and assessed its hepatoprotective potential against APAP-induced hepatotoxicity.</div></div><div><h3>Materials and methods</h3><div>Phytochemical profiling of HEA was conducted using UHPLC/MS. Concentration-response and enzyme kinetics studies determined the IC<sub>50</sub> and the inhibition mechanism of HEA, respectively. Molecular docking predicted interactions between identified compounds and CYP2E1. The hepatoprotective effects were evaluated through co-treatment of <em>L-02</em> hepatocytes (10 mM APAP + 25–100 μg/mL HEA or 4-methylpyrazole [4-MP]) and mice (300 mg/kg APAP + 50–200 mg/kg HEA or 4-MP).</div></div><div><h3>Results</h3><div>HEA inhibited CYP2E1 activity via a mixed-inhibition mechanism, with an IC<sub>50</sub> comparable to that of 4-MP, a CYP2E1 inhibitor. Identified phytochemicals including ellagic acid, kaempferol-3-O-glucuronide, and luteolin-7-O-glucoside exhibited strong binding affinities with CYP2E1. In APAP-treated cells, HEA maintained cell viability and preserved membrane integrity. In APAP-intoxicated mice, HEA reduced serum alanine aminotransferase levels, decreased hepatic malondialdehyde content, preserved normal liver architecture, restored hepatic glutathione levels, enhanced superoxide dismutase and catalase activities, and suppressed CYP2E1 expression and activity.</div></div><div><h3>Conclusion</h3><div>These findings support the ethnopharmacological use of <em>E. africana</em> for liver disorders and highlight its potential as a source of bioactive compounds for the prevention and treatment of drug-induced liver injury.</div></div>","PeriodicalId":15761,"journal":{"name":"Journal of ethnopharmacology","volume":"353 ","pages":"Article 120315"},"PeriodicalIF":5.4000,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of ethnopharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378874125010074","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Ethnopharmacological relevance
Acetaminophen (APAP) poisoning accounts for over 50 % of acute liver failure cases, with N-acetylcysteine remaining the sole antidote despite its limitations. Entada africana, used in ethnomedicine to treat liver disorders, has demonstrated promising antihepatotoxic properties. However, its effects on cytochrome P450 2E1 (CYP2E1) in APAP-toxicity model remain unexplored.
Aims of the study
This study investigated the inhibitory effects of the hydro-ethanolic stem bark extract of E. africana (HEA) on CYP2E1 activity and assessed its hepatoprotective potential against APAP-induced hepatotoxicity.
Materials and methods
Phytochemical profiling of HEA was conducted using UHPLC/MS. Concentration-response and enzyme kinetics studies determined the IC50 and the inhibition mechanism of HEA, respectively. Molecular docking predicted interactions between identified compounds and CYP2E1. The hepatoprotective effects were evaluated through co-treatment of L-02 hepatocytes (10 mM APAP + 25–100 μg/mL HEA or 4-methylpyrazole [4-MP]) and mice (300 mg/kg APAP + 50–200 mg/kg HEA or 4-MP).
Results
HEA inhibited CYP2E1 activity via a mixed-inhibition mechanism, with an IC50 comparable to that of 4-MP, a CYP2E1 inhibitor. Identified phytochemicals including ellagic acid, kaempferol-3-O-glucuronide, and luteolin-7-O-glucoside exhibited strong binding affinities with CYP2E1. In APAP-treated cells, HEA maintained cell viability and preserved membrane integrity. In APAP-intoxicated mice, HEA reduced serum alanine aminotransferase levels, decreased hepatic malondialdehyde content, preserved normal liver architecture, restored hepatic glutathione levels, enhanced superoxide dismutase and catalase activities, and suppressed CYP2E1 expression and activity.
Conclusion
These findings support the ethnopharmacological use of E. africana for liver disorders and highlight its potential as a source of bioactive compounds for the prevention and treatment of drug-induced liver injury.
期刊介绍:
The Journal of Ethnopharmacology is dedicated to the exchange of information and understandings about people''s use of plants, fungi, animals, microorganisms and minerals and their biological and pharmacological effects based on the principles established through international conventions. Early people confronted with illness and disease, discovered a wealth of useful therapeutic agents in the plant and animal kingdoms. The empirical knowledge of these medicinal substances and their toxic potential was passed on by oral tradition and sometimes recorded in herbals and other texts on materia medica. Many valuable drugs of today (e.g., atropine, ephedrine, tubocurarine, digoxin, reserpine) came into use through the study of indigenous remedies. Chemists continue to use plant-derived drugs (e.g., morphine, taxol, physostigmine, quinidine, emetine) as prototypes in their attempts to develop more effective and less toxic medicinals.